Renal Failure, Chronic Clinical Trial
Official title:
Effect of Glucose in Dialysis Water on Blood Pressure and Vasoactive Hormones in Dialysis Patients
The purposes are
1. to measure the effect of dialysis with glucose on blood pressure, pulse rate, plasma
concentration of glucose, plasma concentrations of glucagon, growth hormone, renin,
angiotensin II, endothelin and body temperature, and
2. to analysis the relationship between changes in blood pressure on the one hand and
changes in vasoactive hormones on the other
Measurement of hormones and blood pressure during dialysis treatment. ;
Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00259025 -
Intravenous n-3 Fatty Acids and Sudden Cardiac Death in Hemodialysis Patients
|
Phase 2 | |
| Completed |
NCT00176059 -
Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients
|
Phase 0 | |
| Completed |
NCT00438503 -
Glucose in Dialysis Water in Diabetics With Chronic Renal Failure
|
Phase 4 | |
| Completed |
NCT03904836 -
Tobramycin Administered at the Beginning of Dialysis
|
Phase 1 | |
| Not yet recruiting |
NCT02259296 -
Timing for Arteriovenous Fistula Creation and Its Effect on Target Organs in Patients With Chronic Renal Failure
|
N/A | |
| Completed |
NCT00150891 -
Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection
|
N/A | |
| Completed |
NCT01875523 -
PK of Serelaxin in Severe Renal Impairment and ESRD
|
Phase 1 | |
| Completed |
NCT00438295 -
Temperature Control During Dialysis Treatment
|
Phase 4 | |
| Terminated |
NCT00664066 -
DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)
|
||
| Withdrawn |
NCT00262353 -
Elimination of Protein-bound Uremic Retention Solutes by Prometheus Artificial Hepatic System Versus Conventional Dialysis
|
N/A |